Blackstone made its foray in the sector last year, acquiring Clarus, an investment firm specializing in life sciences. For its part, Ferring will invest $170 million in the joint venture with Blackstone, dubbed FerGene, bringing its total funding to $570 million, the companies said in a statement. …read more […]
Blackstone Group Inc said on Monday it will invest $400 million in a joint venture with Swiss drug company Ferring that is working on an experimental gene therapy for bladder cancer, the private equity giant’s largest ever bet on drug development.
Dividend paying stocks like Cognizant Technology Solutions Corporation (NASDAQ:CTSH) tend to be popular with… …read more […]
A U.S.-based foundation overseeing promising semiconductor technology developed with Pentagon support will soon move to Switzerland after several of the group’s foreign members raised concerns about potential U.S. trade curbs.
A.P. Moller-Maersk’s finance chief Carolina Dybeck Happe will leave the shipping group to take up a similar position at General Electric early next year, the companies said on Monday.
General Electric Co has named Carolina Dybeck Happe, currently finance chief at shipper AP Moller-Maersk as its chief financial officer, the latest in a slew of management changes aimed at stabilizing the U.S. industrial conglomerate.
U.S. stock index futures rose on Monday as expectations of a trade truce were strengthened by a report that the world’s two largest economies were “very close” to a deal, while jeweler Tiffany surged after agreeing to a sale.
Sorrento Therapeutics Inc said on Monday it had rejected an unsolicited buyout proposal from two pharmaceutical companies, saying it significantly undervalued the drugmaker and was not in the best interests of its shareholders. The all-cash deal on Saturday offered between $3 and $5 for each of Sorrento’s outstanding shares, the company said. At the higher-end of the offer, Sorrento would have been valued at $709.4 million, while its current market capitalization stands at nearly $227 million. …read more […]
Charles Schwab and TD Ameritrade are hooking up. So what does the planned marriage mean for the average investor? …read more […]
World shares staged a cautious rally on Monday as investors held out for some progress in U.S.-China trade talks, while the dollar dipped after its latest rally on the back of strong U.S. economic data.
Chinese buyers scooped up at least 20 cargoes of Brazilian soybeans last week due to uncertainty over a trade deal with the United States that sent them rushing to lock in supplies, traders said on Monday.
General Electric shares were little changed on the news. …read more […]
Charles Schwab Corp will buy TD Ameritrade Holding Corp in an all-stock deal valued at $26 billion, the two largest U.S. discount brokerages said on Monday, as they try to fend off competition from newer rivals.
General Electric Co has named Carolina Dybeck Happe, currently finance chief at shipper AP Moller-Maersk as its chief financial officer, bringing in more new blood at the top of the struggling U.S. industrial conglomerate.
Following an equity payment default by Emerald Health Therapeutics (OTCQB: EMHTF) under the Delta 2 option agreement involving Pure Sunfarms, Village Farms International (TSX: VFF) (NASDAQ: VFF) has informed Pure Sunfarms of exercising its rights to increase its ownership in Pure Sunfarms and advanced an equity payment to Pure Sunfarms of $5.94 million. Emerald was obligated to […]The post Village Farms Eyes Increased Position in Pure Sunfarms appeared first on Market Exclusive. …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
